, Tracking Stock Market Picks
Enter Symbol:
China Bio Energy (CBEH) [hlAlert]

Mkt Outperform
down 98.68 %

China Bio Energy (CBEH) rated Mkt Outperform with price target $12.50 by Rodman & Renshaw

Posted on: Friday,  May 14, 2010  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform China Bio Energy (OTCBB: CBEH) on 05/14/2010, when the stock price was $9.16.
Since then, China Bio Energy has lost 98.69% as of 11/12/2014's recent price of $0.12.
If you would have followed this Rodman & Renshaw's recommendation on CBEH, you would have lost 98.68% of your investment in 1643 days.

China Integrated Energy, Inc., formerly China Bio Energy Holding Group Co., Ltd., is engaged in three business segments, the development, exploration, production, and distribution of bio-diesel, the wholesale distribution and processing of heavy oil and finished oil products, and the sale of gasoline and diesel at retail gas stations. The Company has one wholly owned subsidiary, Baorun China Group Limited (Baorun Group) and two indirectly owned subsidiaries, Redsky Industrial (Xi?an) Co., Ltd. (Redsky Industrial) and Xi?an Baorun Industrial Development Co., Ltd. (Baorun Industrial).

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/14/2010 8:25 AM Buy
9.16 12.50
as of 12/31/2010
1 Week down  -20.24 %
1 Month down  -20.87 %
3 Months down  -11.19 %
1 YTD down  -35.04 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy